Literature DB >> 1422316

Cytological and ultrastructural investigation on osteoblastic and preosteoclastic cells grown in vitro in the presence of ipriflavone: preliminary results.

E Bonucci1, G Silvestrini, P Ballanti, L Masi, A Franchi, L Bufalino, M L Brandi.   

Abstract

The effects of ipriflavone on bone cells were studied in vitro on pre-osteoclastic (FLG 29.1) and osteoblast-like (Saos-2) cells grown for 48 h either separately or in co-cultures, with or without the addition of PTH. Histological, ultrastructural and histochemical (TRAP-activity demonstration) methods were used. The main results show that ipriflavone reduces replication of FLG 29.1 cells and inhibits TRAP production by these cells both in controls and in co-cultures treated with PTH. Moreover, it has a moderate stimulatory effect on proliferation of osteoblast-like cells and reduces the PTH-induced degenerative changes of Saos-2 cells. These results suggest that the inhibitory effect of ipriflavone on FLG 29.1 cells might be indirect and might be mediated by the osteoblast-like cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422316     DOI: 10.1016/0169-6009(92)90862-8

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  6 in total

1.  Ipriflavone: new insights into its mechanisms of action on bone remodeling.

Authors:  M L Brandi; C Gennari
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

2.  Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.

Authors:  K Notoya; S Taketomi; M Tsuda
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

3.  Ipriflavone improves bone density and biomechanical properties of adult male rat bones.

Authors:  R Civitelli; S H Abbasi-Jarhomi; L R Halstead; A Dimarogonas
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

4.  Interactions between ipriflavone and the estrogen receptor.

Authors:  M Petilli; G Fiorelli; S Benvenuti; U Frediani; F Gori; M L Brandi
Journal:  Calcif Tissue Int       Date:  1995-02       Impact factor: 4.333

5.  Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass.

Authors:  M Valente; L Bufalino; G N Castiglione; R D'Angelo; A Mancuso; P Galoppi; L Zichella
Journal:  Calcif Tissue Int       Date:  1994-05       Impact factor: 4.333

6.  Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites.

Authors:  S L Cheng; S F Zhang; T L Nelson; P M Warlow; R Civitelli
Journal:  Calcif Tissue Int       Date:  1994-11       Impact factor: 4.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.